China Pharma Holdings Inc Working Capital to Net Assets Ratio
China Pharma Holdings Inc working capital to net assets ratio. China Pharma Holdings Inc (CPHI) has a Working Capital to Net Assets ratio of -50.5% as of September 2025. Working capital of $-4.29 Million (current assets of $2.33 Million minus current liabilities of $6.62 Million) is measured against net assets of $8.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of China Pharma Holdings Inc (2001–2024)
Working capital to net assets ratio of China Pharma Holdings Inc from 2001 to 2024. This chart shows how China Pharma Holdings Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the ratio stands at -50.5%, reflecting working capital of $-4.29 Million against net assets of $8.49 Million USD. See CPHI days of operational coverage to measure how many days the company can operate on defensive assets alone.
China Pharma Holdings Inc Working Capital to Net Assets Ratio by Year (2001–2024)
China Pharma Holdings Inc working capital to net assets ratio by year from 2001 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for China Pharma Holdings Inc from 2001 to 2024, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is China Pharma Holdings Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -22.5% | $-1.75 Million | $7.75 Million | $3.27 Million | $5.02 Million | ▼ -11.5 pp |
| 2023 | -11.0% | $-823.73K | $7.45 Million | $6.00 Million | $6.82 Million | ▲ +146.9 pp |
| 2022 | -157.9% | $-6.77 Million | $4.29 Million | $5.96 Million | $12.74 Million | ▼ -134.3 pp |
| 2021 | -23.6% | $-1.42 Million | $6.02 Million | $9.09 Million | $10.51 Million | ▲ +52.4 pp |
| 2020 | -76.0% | $-6.08 Million | $8.00 Million | $5.32 Million | $11.40 Million | ▼ -27.6 pp |
| 2019 | -48.3% | $-4.47 Million | $9.24 Million | $5.58 Million | $10.05 Million | ▼ -44.0 pp |
| 2018 | -4.3% | $-1.30 Million | $30.20 Million | $8.75 Million | $10.05 Million | ▼ -11.4 pp |
| 2017 | 7.1% | $3.06 Million | $43.07 Million | $12.29 Million | $9.23 Million | ▼ -5.0 pp |
| 2016 | 12.1% | $7.12 Million | $58.91 Million | $17.52 Million | $10.40 Million | ▼ -4.7 pp |
| 2015 | 16.7% | $12.17 Million | $72.64 Million | $24.96 Million | $12.79 Million | ▼ -21.2 pp |
| 2014 | 37.9% | $40.32 Million | $106.25 Million | $54.49 Million | $14.17 Million | ▼ -16.2 pp |
| 2013 | 54.1% | $71.95 Million | $132.94 Million | $83.96 Million | $12.01 Million | ▼ -11.8 pp |
| 2012 | 65.9% | $97.90 Million | $148.52 Million | $112.53 Million | $14.63 Million | ▼ -2.0 pp |
| 2011 | 68.0% | $96.83 Million | $142.48 Million | $110.61 Million | $13.78 Million | ▲ +0.9 pp |
| 2010 | 67.1% | $79.13 Million | $117.94 Million | $91.93 Million | $12.81 Million | ▼ -0.2 pp |
| 2009 | 67.3% | $60.79 Million | $90.40 Million | $71.30 Million | $10.51 Million | ▼ -10.3 pp |
| 2008 | 77.5% | $54.16 Million | $69.87 Million | $59.73 Million | $5.57 Million | ▼ -10.3 pp |
| 2007 | 87.8% | $34.92 Million | $39.76 Million | $38.83 Million | $3.91 Million | ▲ +1.1 pp |
| 2006 | 86.7% | $18.07 Million | $20.85 Million | $25.71 Million | $7.63 Million | ▼ -13.3 pp |
| 2005 | 100.0% | $-68.32K | $-68.32K | $84.00 | $68.41K | ▲ +0.0 pp |
| 2004 | 100.0% | $-68.32K | $-68.32K | $84.00 | $68.41K | ▼ -22.9 pp |
| 2003 | 122.9% | $-902.26K | $-733.96K | $3.55K | $905.82K | ▲ +4.7 pp |
| 2002 | 118.2% | $-669.63K | $-566.35K | $3.84K | $673.47K | ▲ +0.0 pp |
| 2001 | 118.2% | $-669.63K | $-566.35K | $3.84K | $673.47K | — |